ANVISA registration

Família Atellica IM Anti-Tiroglobulina II (aTgII)

Registration 10345162375. TIREOGLOBULINA (TG) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER

Registration details

Registration number10345162375
Application number25351271101202066
Technical nameTIREOGLOBULINA (TG) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER
Risk classIII
Published on10/08/2020
ValidityValid until 03/11/2035

Registration holder

Legal nameSIEMENS HEALTHCARE DIAGNÓSTICOS LTDA
CNPJ01.449.930/0001-90

Manufacturer

  • SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD. REINO UNIDO

Other registrations held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAview all

FAMÍLIA CA 19-9 DILUENT

10345160005

ADVIA CENTAUR TSH

10345160012

ADVIA CENTAUR T4

10345160013

ADVIA CENTAUR T3/T4 /VB12 ANCILLARY REAGENT

10345160015

ADVIA CENTAUR FT3

10345160017

ADVIA CENTAUR T3

10345160018

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist